In early 1997, some of the patients at the Johns Hopkins
University Medical Center‘s Chronic Fatigue Syndrome (C.F.S.) studies in Baltimore, reported good results while using
Vitalyte Electrolyte Replacement, known then as “Gookinaid E.R.G.”* Karen DeBusk, R.N., the director of the study at Johns Hopkins, requested a supply of Gookinaid™ for use in evaluating its effectiveness in relieving the
malaise fatigue and lassitude that characterizes C.F.S. Results were so dramatic that Gookinaid was recommended as a supplement to drug therapy for the syndrome, as well as for other dehydration and electrolyte imbalance conditions, including: other neurological or hormonal induced electrolyte imbalance syndromes, and for patients who have had a portion of their digestive tract removed, limiting the return of fluids and electrolytes to the system.
Patients who suffer from chronic fatigue syndrome are found to have low electrolyte and fluid levels, accompanied by hypotonicity (low blood pressure). Low electrolyte and fluid levels are the major factors in fatigue. In individuals with C.F.S., the autonomic nervous system is sending “mixed” signals to the endocrine system causing the body to lose more electrolytes, especially sodium and potassium, in urine than normal. This causes greater electrolyte and fluid loss, resulting in lowered blood volume and blood pressure. Therapy with experimental drugs to readjust the hormonal signals to help maintain normal electrolyte levels and reduce diuresis supported by oral fluid and electrolyte replacement has been very effective in helping the C.F.S. individuals resume more normally functional lives. The only
electrolyte replacement drink found to be really effective in maintaining electrolyte and fluid levels is
VITALYTE™ lytes to the system.